4-(Chloromethyl)-2-methyl-1,3-thiazole--hydrogen chloride (1/1) → HCID 66707040, compound
Reaction equation
C(OC([N:8]1[CH2:14][CH2:13][C:12]2[C:15]([S:20][C:21](=O)N(C)C)=[C:16]([Cl:19])[CH:17]=[CH:18][C:11]=2[CH2:10][CH2:9]1)=O)(C)(C)C.Cl.ClC[C:29]1[N:30]=[C:31]([CH3:34])[S:32][CH:33]=1>>[ClH:19].[Cl:19][C:16]1[CH:17]=[CH:18][C:11]2[CH2:10][CH2:9][NH:8][CH2:14][CH2:13][C:12]=2[C:15]=1[S:20][CH2:21][C:29]1[N:30]=[C:31]([CH3:34])[S:32][CH:33]=1Participants
3
Procedure
Use a method similar to the Example 332, using 3-tert-butoxycarbonyl-7-chloro-6-dimethylcarbamoylthio-2,3,4,5-tetrahydro-1H-benzo[d]azepine and 4-chloromethyl-2-methylthiazole hydrochloride to give, after deprotection by the General Procedure 1-4, the title compound as a white solid. MS (APCI+) m/z: 325 (M+H)+.
Workup
- customto give
Sources & evidence
- ORD record
- ord-76867ac5984b4422b2d82c5ee509e4f9
- Source dataset
- uspto-grants-2011_09
- Patent number
- US08022062B2
Reaction notes
Loading…